Clinical Trial Update: Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial testing nitrocamptothecin versus fluorouracil in patients with recurrent or refractory pancreatic cancer. Current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Pancreatic Cancer | Phase 3 | Status: UNKNOWN